发明名称 |
Menetelmä terapeuttisesti käyttökelpoisen 2,3,4,5,6,7-heksahydro-1-(4- 1-/4-(2-metoksifenyyli)piperatsinyyli/ -2-fenyylibutyryyli)-1H-atsepiinin tai sen farmaseuttisesti hyväksyttävän happoadditiosuolan valmis tamiseksi |
摘要 |
2,3,4,5,6,7-Hexahydro-1-(4-[1-[4-(2- methoxyphenyl)piperazinyl]]-2-phenylbutyryl)-1H-azepine and its pharmaceutically acceptable acid addition salts are 5-HT1A-binding agents which can be used as anxiety- alleviating agents. The invention also relates to the preparation of the said compounds and to compositions which comprise them. <IMAGE>
|
申请公布号 |
FI920945(A) |
申请公布日期 |
1993.09.04 |
申请号 |
FI19920000945 |
申请日期 |
1992.03.03 |
申请人 |
JOHN WYETH & BROTHER LIMITED |
发明人 |
CLIFFE, IAN ANTHONY |
分类号 |
C07D;C07D215/18 |
主分类号 |
C07D |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|